AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Home Mycology Article
Article Link
Collect
Submit Manuscript
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Review | Open Access

Current and future perspective on antimicrobial and anti-parasitic activities of Ganoderma sp.: an update

Buddha Bahadur Basneta,bLi Liua,cLi Baoa,c( )Hongwei Liua,c( )
State Key Laboratory of Mycology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, People’s Republic of China
International College, University of Chinese Academy of Sciences, Beijing, People’s Republic of China
Savaid Medical School, University of Chinese Academy of Sciences, Beijing, People’s Republic of China
Show Author Information

Abstract

Medicinal mushroom Ganoderma sp. is considered to be a key source for the production of therapeutic agents. Our current review indicates that a limited number (<19%; 79 out of >430) of isolated compounds have been tested and known to be active against several microorganisms and parasites. In this review, we aim to summarise all the antimicrobial and anti-parasitic works on Ganoderma sp. displayed on web of science, google scholar and endnote X7 from 1932 to August 2016. We further present and discuss the structure of active compounds against microorganisms and parasites. In addition, we also discuss the possible further research to identify lead compounds from Ganoderma sp. as a novel strategy to combat the potential global emergence of bad bugs and parasites.

References

 

Adams M, Christen M, Plitzko I, Zimmermann S, Brun R, Kaiser M, Hamburger M. 2010. Anti plasmodial Lanostanes from the Ganoderma lucidum Mushroom. J Nat Prod. 73: 897–900.

 

Al-Fatimi M, Wurster M, Kreisel H, Lindequist U. 2005. Antimicrobial, cytotoxic and antioxidant activity of selected basidiomycetes from Yemen. Pharmazie. 60: 776–780.

 

Baby S, Johnson AJ, Govindan B. 2015. Secondary metabolites from Ganoderma. Phytochem. 114: 66–101.

 

Chuang CM, Wang HE, Chang CH, Peng CC, Ker YB, Lai JE, Chen KC, Peng RY. 2013. Sacchachitin, a novel chitin-polysaccharide conjugate macromolecule present in Ganoderma lucidum: purification, composition, and properties. Pharm Biol. 51: 84–95.

 

Ćilerdžić J, Vukojević J, Stajić M, Stanojković T, Glamočlija J. 2014. Biological activity of Ganoderma lucidum basidiocarps cultivated on alternative and commercial substrate. J Ethnopharmacol. 155: 312–319.

 

Cilerdzic J, Stajic M, Vukojevic J. 2016. Potential of submergedly cultivated mycelia of Ganoderma spp. as antioxidant and antimicrobial agents. Curr Pharm Biotechnol. 17: 275–282.

 

Donatini B. 2014. Control of Oral Human Papillomavirus (HPV) by medicinal mushrooms, trametes versicolor and Ganoderma lucidum: A preliminary clinical trial. Int J Med Mucshrooms. 16: 497-498.

 

El Dine RS, El Halawany AM, Ma C-M, Hattori M. 2008. Anti-HIV1 Protease Activity of Lanostane Triterpenes from the Vietnamese Mushroom Ganoderma colossum. J Nat Prod. 71: 1022–1026.

 

El Dine RS, El Halawany AM, Ma C-M, Hattori M. 2009. Inhibition of the Dimerization and Active Site of HIV-1 Protease by Secondary Metabolites from the Vietnamese Mushroom Ganoderma colossum. J Nat Prod. 72: 2019–2023.

 

El-Mekkawy S, Meselhy MR, Nakamura N, Tezuka Y, Hattori M, Kakiuchi N, Shimotohno K, Kawahata T, Otake T. 1998. Anti-HIV-1 and anti-HIV-1-protease substances from Ganoderma lucidum. Phytochem. 49: 1651–1657.

 

Eo SK, Kim YS, Lee CK, Han SS. 2000. Possible mode of antiviral activity of acidic protein bound polysaccharide isolated from Ganoderma lucidum on herpes simplex viruses. J Ethnopharmacol. 72: 475–481.

 

Ferreira ICFR, Heleno SA, Reis FS, Stojkovic D, Queiroz MJRP, Vasconcelos MH, Sokovic M. 2015. Chemical features of Ganoderma polysaccharides with antioxidant, antitumor and antimicrobial activities. Phytochem. 114: 38–55.

 

Heleno SA, Ferreira IC, Esteves AP, Ćirić A, Glamočlija J, Martins A, Soković M, Queiroz MJR. 2013. Antimicrobial and demelanizing activity of Ganoderma lucidum extract, p-hydroxybenzoic and cinnamic acids and their synthetic acetylated glucuronide methyl esters. Food Chemtoxicol. 58: 95–100.

 
Hill RA, Connolly JD. 2013. Triterpenoids. Nat Prod Rep30: 1028–1065. Available from: http://www.speciesfungorum.org/
 

Huie CW, Di X. 2004. Chromatographic and electrophoretic methods for Lingzhi pharmacologically active components. J Chromatogr B Analyt Technol Biomed Life Sci. 812:241–257.

 

Isaka M, Chinthanom P, Sappan M, Danwisetkanjana K, Boonpratuang T, Choeyklin R. 2016. Antitubercular Lanostane Triterpenes from Cultures of the Basidiomycete Ganoderma sp. BCC 16642. J Nat Prod. 79:161–169.

 

Iwatsuki K, Akihisa T, Tokuda H, Ukiya M, Oshikubo M, Kimura Y, Asano T, Nomura A, Nishino H. 2003. Lucidenic Acids P and Q, Methyl Lucidenate P, and Other Triterpenoids from the Fungus Ganoderma lucidum and Their inhibitory effects on epstein−barr virus activation. J Nat Prod. 66:1582–1585.

 
Karwa A, Rai M. 2012. Naturally occurring medicinal mushroom-derived antimicrobials: A case-study using lingzhi or reishi Ganoderma Iucidum (W. Curt.: fr.) P. Karst. (Higher Basidiomycetes). Int J Med Mushrooms.14: 481.
 

Lakornwong W, Kanokmedhakul K, Kanokmedhakul S, Kongsaeree P, Prabpai S, Sibounnavong P, Soytong K. 2014. Triterpene Lactones from Cultures of Ganoderma sp. KM01. J Nat Prod. 77:1545–1553.

 

Li WJ, Nie SP, Liu XZ, Zhang H, Yang Y, Yu Q, Xie MY. 2012. Antimicrobial properties, antioxidant activity and cytotoxicity of ethanol-soluble acidic components from Ganoderma atrum. Food Chem Toxicol. 50:689–694.

 

Li Y, Yang Y, Fang L, Zhang Z, Jin J, Zhang K. 2006. Anti-hepatitis activities in the broth of Ganoderma lucidum supplemented with a Chinese herbal medicine. Am J Chin Med. 34:341–349.

 

Li YQ, Wang SF. 2006. Anti-hepatitis B activities of ganoderic acid from Ganoderma lucidum. Biotechnol Lett. 28:837–841.

 

Liu DZ, Zhu YQ, Li XF, Shan WG, Gao PF. 2014. New triterpenoids from the fruiting bodies of Ganoderma lucidum and their bioactivities. ChemBiodivers. 11:982–986.

 

Ma K, Ren JW, Han JJ, Bao L, Li L, Yao YJ, Sun C, Zhou B, Liu HW. 2014. Ganoboninketals A–C, antiplasmodial 3,4-seco-27-norlanostane triterpenes from Ganoderma boninense Pat. J Nat Prod. 77:1847–1852.

 

Mikolasch A, Hildebrandt O, Schlüter R, Hammer E, Witt S, Lindequist U. 2016. Targeted synthesis of novel β-lactam antibiotics by laccase-catalyzed reaction of aromatic substrates selected by pre-testing for their antimicrobial and cytotoxic activity. Appl Microbiol Biotechnol. 100:4885–4899.

 

Mothana RAA, Jansen R, Jülich WD, Lindequist U. 2000. Ganomycins A and B, New antimicrobial farnesyl hydroquinones from the basidiomycete Ganoderma pfeifferi. J Nat Prod. 63:416–418.

 

MothanaRa A, Awadh Ali NA, Jansen R, Wegner U, Mentel R, Lindequist U. 2003. Antiviral lanostanoid triterpenes from the fungus Ganoderma pfeifferi. Fitoterapia. 74:177–180.

 

Niedermeyer THJ, Lindequist U, Mentel R, Gördes D, Schmidt E, Thurow K, Lalk M. 2005. Antiviral terpenoid constituents of Ganoderma pfeifferi. J Nat Prod. 68:1728–1731.

 

Ofodile LN, Ogbe AO, Oladipupo O. 2011. Effect of the mycelial culture of Ganoderma lucidum on human pathogenic bacteria. Int J Biol. 3: 111-114.

 

Ofodile LN, Uma NU, Kokubun T, Grayer RJ, Ogundipe OT, Simmonds MSJ. 2005. Antimicrobial activity of some Ganoderma species from Nigeria. Phytother Res. 19:310–313.

 

Oluba OM, Olusola AO, Fagbohunka BSOnyeneke E. 2012. (w.curt.:fr.)p.karst.(higher basidiomycetes), in plasmodium berghei-infected mice. antimalarial And Hepatoprotective Effects Of Crude Ethanolic Extract Of lingzhi Or Reishi Medicinal mushroom, Ganoderma Lucidum. 14:459-466.

 
Paterson RRM. 2006. Ganoderma – A therapeutic fungal biofactory. In: Phytochem. 67: 1985–2001.
 

Rai MK, Gaikwad S, Nagaonkar D, Dos Santos CA. 2015. Current advances in the antimicrobial potential of species of genus ganoderma (Higher basidiomycetes) against human pathogenic microorganisms (Review). Int J Med Mucshrooms. 17: 921-932.

 

Sa-Ard P, Sarnthima R, Khammuang S, Kanchanarach W. 2015. Antioxidant, antibacterial and DNA protective activities of protein extracts from Ganoderma lucidum. J Food Sci Technol. 52:2966–2973.

 

Sanodiya BS, Thakur GS, Baghel RK, Prasad G, Bisen PS. 2009. Ganoderma lucidum: a potent pharmacological macrofungus. Curr Pharm Biotechnol. 10:717–742.

 

Sato N, Zhang Q, Ma C-M, Hattori M. 2009. Anti-human immunodeficiency virus-1 protease activity of new lanostane-type triterpenoids from Ganoderma sinense. Chem Pharm Bull. 57:1076–1080.

 

Shamaki BU, Sandabe UK, Ogbe AO, Abdulrahman FI, El-Yuguda A-D. 2014. Methanolic soluble fractions of lingzhi or reishi medicinal mushroom, Ganoderma lucidum (Higher basidiomycetes) Extract inhibit neuraminidase activity in newcastle disease virus (LaSota). Int J Med Mushrooms. 16: 579-583.

 

Shang X, Tan Q, Liu R, Yu K, Li P, Zhao G-P. 2013. In vitro anti-Helicobacter pylori effects of medicinal mushroom extracts, with special emphasis on the Lion’s Mane mushroom, Hericium erinaceus (higher Basidiomycetes). Int J Med Mushrooms. 15: 165-174.

 

Smania EFA, DelleMonache F, Smania A, Yunes RA, Cuneo RS. 2003. Antifungal activity of sterols and triterpenes isolated from Ganoderma annulare. Fitoterapia. 74:375–377.

 

Sun X, Jin X, Pan W, Wang J. 2014. Syntheses of new rare earth complexes with carboxymethylated polysaccharides and evaluation of their in vitro antifungal activities. Carbohydr Polym. 113:194–199.

 

Vazirian M, Faramarzi MA, Ebrahimi SES, Esfahani HRM, Samadi N, Hosseini SA, Asghari A, Manayi A, Mousazadeh SA, Asef MR, et al. 2014. Antimicrobial effect of the Lingzhi or Reishi medicinal mushroom, Ganoderma lucidum (higher Basidiomycetes) and its main compounds. Int J Med Mushrooms. 16: 77-84.

 

Wang H, Ng TB. 2006. Ganodermin, an antifungal protein from fruiting bodies of the medicinal mushroom Ganoderma lucidum. Peptides. 27:27–30.

 

Xia Q, Zhang H, Sun X, Zhao H, Wu L, Zhu D, Yang G, Shao Y, Zhang X, Mao X, et al. 2014. A comprehensive review of the structure elucidation and biological activity of triterpenoids from Ganoderma spp. Molecules. 19:17478–17535.

 

Yoon SY, Eo SK, Kim YS, Lee CK, Han SS. 1994. Antimicrobial activity of Ganoderma lucidum extract alone and in combination with some antibiotics. Arch Pharm Res. 17:438–442.

 

Zengin G, Sarikurkcu C, Gunes E, Uysal A, Ceylan R, Uysal S, Gungor H, Aktumsek A. 2015. Two Ganoderma species: profiling of phenolic compounds by HPLC–DAD, antioxidant, antimicrobial and inhibitory activities on key enzymes linked to diabetes mellitus, Alzheimer’s disease and skin disorders. Food Funct. 6:2794–2802.

 

Zhang SS, Wang YG, Ma QY, Huang SZ, Hu LL, Dai HF, Yu ZF, Zhao YX. 2015. Three new lanostanoids from the mushroom Ganoderma tropicum. Molecules. 20:3281–3289.

 

Zhang W, Tao J, Yang X, Yang Z, Zhang L, Liu H, Wu K, Wu J. 2014. Antiviral effects of two Ganoderma lucidum triterpenoids against enterovirus 71 infection. Biochem Biophys Res Commun. 449:307–312.

 

Zhao S, Guo YX, Liu QH, Wang HX, Ng TB. 2009. Lectins but not antifungal proteins exhibit anti-nematode activity. Environ Toxicol Pharmacol. 28:265–268.

Mycology
Pages 111-124
Cite this article:
Basnet BB, Liu L, Bao L, et al. Current and future perspective on antimicrobial and anti-parasitic activities of Ganoderma sp.: an update. Mycology, 2017, 8(2): 111-124. https://doi.org/10.1080/21501203.2017.1324529

148

Views

31

Crossref

0

Web of Science

34

Scopus

Altmetrics

Received: 21 February 2017
Accepted: 25 April 2017
Published: 24 May 2017
© 2017 The Author(s).

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Return